Mavoglurant (AFQ056) is an experimental drug candidate for the treatment of fragile X syndrome.It exerts its effect as an antagonist of the metabotropic glutamate receptor 5 (mGLU5).
Molecular Weight:
313.3908
CAS Number:
[543906-09-8]
Formula:
C19NO3H23
* VAT and and shipping costs not included. Errors and price changes excepted